Leu Kinib 50mg Tablet
Marketer
Sayre Therapeutics Pvt Ltd
Salt Composition
Dasatinib (50mg)
Overview Leu Kinib 50mg Tablet
Chronic myeloid leukemia (CML) patients whose condition is unresponsive to, or intolerant of, other treatments may benefit from Leu Kinib 50mg tablets. This medication can be administered with or without food, but consistent daily timing is recommended for optimal efficacy. Dosage and frequency are determined by your physician based on individual needs and may be adjusted. Strict adherence to your doctor's prescribed regimen is crucial, as incorrect usage or overdosing can lead to severe adverse effects. While therapeutic benefits may not be apparent for several weeks or months, discontinue use only as directed by your physician. Common side effects include nausea, vomiting, abdominal pain, and rash. Increased heart rate and blood pressure fluctuations (high or low) are possible; consult your doctor immediately if these occur. Regular blood pressure monitoring may be implemented. Avoid antacids within two hours of taking Leu Kinib. This medication can lower blood cell counts, increasing infection risk, necessitating regular blood tests. Inform your healthcare provider of all other medications you are taking, as interactions are possible. Leu Kinib is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or blurred vision develops.
Uses of Leu Kinib 50mg Tablet
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Leu Kinib 50mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 50mg Leu Kinib tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
Common Side effects of Leu Kinib 50mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Leu Kinib 50mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Leu Kinib 50mg Tablets can be consumed with or without food; however, consistent timing is recommended.
How Leu Kinib 50mg Tablet works:
Kinase inhibitor Leu Kinib, in its 50mg tablet form, combats cancer by targeting and neutralizing the aberrant protein responsible for prompting cancerous cell proliferation, thus inhibiting or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Leu Kinib 50mg Tablet may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Use of Leu Kinib 50mg Tablets is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Leu Kinib 50mg Tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Leu Kinib 50mg Tablet side effects. Exercise caution while driving if you experience dizziness or blurred vision after taking Leu Kinib 50mg Tablet.
KidneySAFE IF PRESCRIBED
The use of Leu Kinib 50mg Tablets in patients with kidney disease is likely safe. Current evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Leu Kinib 50mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Leu Kinib 50mg Tablet :
Omit any missed Leu Kinib 50mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Leu Kinib 50mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently